Capri, Rogelyn G.
HRN: 26-32-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2025
CO-AMOXICLAV 625MG (TAB)
04/21/2025
04/27/2025
PO
625mg
BID
Thinly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes